EUVIMEDEUVIMED entdecken
Open Access

Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation

Yueh-Chien Lin iD, Steven Swendeman iD, Irina S Moreira iD, Avishek Ghosh iD, Andrew Kuo iD, Nícia Rosário-Ferreira, Shihui Guo iD, Alan Culbertson, Michel V Levesque iD, Andreane Cartier iD, Takahiro Seno iD, Alec Schmaier iD und 9 weitere

Science Signaling · 2024

DOI: 10.1126/scisignal.adg9256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Yueh-Chien Lin und 20 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Apolipoproteins, Lipocalins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Heart Association-American Stroke Association, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-density lipoprotein (HDL) nanoparticles promote endothelial cell (EC) function and suppress inflammation, but their utility in treating EC dysfunction has not been fully explored. Here, we describe a fusion protein named ApoA1-ApoM (A1M) consisting of apolipoprotein A1 (ApoA1), the principal structural protein of HDL that forms lipid nanoparticles, and ApoM, a chaperone for the bioactive lipid sphingosine 1-phosphate (S1P). A1M forms HDL-like particles, binds to S1P, and is signaling competent. Molecular dynamics simulations showed that the S1P-bound ApoM moiety in A1M efficiently activated EC surface receptors. Treatment of human umbilical vein ECs with A1M-S1P stimulated barrier function either alone or cooperatively with other barrier-enhancing molecules, including the stable prostacyclin analog iloprost, and suppressed cytokine-induced inflammation. A1M-S1P injection into mice during sterile inflammation suppressed neutrophil influx and inflammatory mediator secretion. Moreover, systemic A1M administration led to a sustained increase in circulating HDL-bound S1P and suppressed inflammation in a murine model of LPS-induced endotoxemia. We propose that A1M administration may enhance vascular endothelial barrier function, suppress cytokine storm, and promote resilience of the vascular endothelium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApolipoproteinsLipocalinsHumansMiceAnimalsReceptors, LysosphingolipidApolipoproteins MInflammationLipoproteins, HDLLysophospholipidsSphingosine

Substanzen

ApolipoproteinsLipocalinsReceptors, LysosphingolipidApolipoproteins MLipoproteins, HDLLysophospholipidsSphingosine

Autor:innen und Institutionen

  • Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
  • CNC-Center for Neuroscience and Cell Biology, Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3000-456 Coimbra, Portugal.
  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115 USA.
  • Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Yueh-Chien Lin, Steven Swendeman, Irina S Moreira, Avishek Ghosh, Andrew Kuo, Shihui Guo, Michel V Levesque, Andreane Cartier, Takahiro Seno, Alec Schmaier, Asuka Inoue, Samir M Parikh, Garret A FitzGerald, David Zurakowski, Maofu Liao, Zeynep H Gümüş, Timothy Hla

Förderung

  • NCI NIH HHS
  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • NEI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Lin, Y. C., Swendeman, S., Moreira, I. S., Ghosh, A., Kuo, A., Rosário-Ferreira, N., Guo, S., Culbertson, A., Levesque, M. V., Cartier, A., Seno, T., Schmaier, A., Galvani, S., Inoue, A., Parikh, S. M., FitzGerald, G. A., Zurakowski, D., Liao, M., Flaumenhaft, R., …, & Hla, T. (2024). Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation. Science Signaling. https://doi.org/10.1126/scisignal.adg9256

Vancouver

Lin YC, Swendeman S, Moreira IS, Ghosh A, Kuo A, Rosário-Ferreira N, et al. Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation. Science Signaling. 2024. doi:10.1126/scisignal.adg9256

BibTeX
@article{Lin2024,
  author = {Lin, Yueh-Chien and Swendeman, Steven and Moreira, Irina S and Ghosh, Avishek and Kuo, Andrew and Rosário-Ferreira, Nícia and Guo, Shihui and Culbertson, Alan and Levesque, Michel V and Cartier, Andreane and Seno, Takahiro and Schmaier, Alec and Galvani, Sylvain and Inoue, Asuka and Parikh, Samir M and FitzGerald, Garret A and Zurakowski, David and Liao, Maofu and Flaumenhaft, Robert and Gümüş, Zeynep H and Hla, Timothy},
  title = {Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation},
  journal = {Science Signaling},
  year = {2024},
  doi = {10.1126/scisignal.adg9256}
}
Kostenlos starten →